{"page":"https://casescribe.ai/explorer/regulation-changes/2017-12-04","generated_at":"2026-10-03T18:29:27.098Z","data_as_of":{"decisions":944125,"first_year":2017,"last_year":2026,"latest_decision":"2026-04-30","cfr":"2026-10-01","m21":"2026-09-29"},"about":{"publisher":"CaseScribe AI (VA Law Explorer)","source":"Public Board of Veterans' Appeals decisions (appeals of VA decisions, not VA's first decisions), M21-1 Adjudication Procedures Manual, 38 CFR Parts 3 and 4.","method":"Outcomes are issue-level: each condition the Board decided in a decision counts once. Decision data is extracted by AI and can contain errors. Rates describe past appeals and do not predict any claim.","disclaimer":"For research only. CaseScribe AI is not a law firm and this is not legal advice. Verify figures against the source decisions and regulations.","attribution":"Cite as: VA Law Explorer, CaseScribe AI, with the page URL."},"data":{"week_of":"2017-12-04","changes":[{"source":"38 CFR","section":"Schedule of ratings - cardiovascular system.","date":"2017-12-10","url":"https://www.ecfr.gov/current/title-38/section-4.104","formatting_only":false,"added":["7008 Hyperthyroid heart disease.","| Rate under the appropriate cardiovascular diagnostic code, depending on particular findings.","13, 2014;","82 FR 50804, Dec.","11, 2017]"],"removed":["Link to an amendment published at 82 FR 50804, Nov.","2, 2017.","7008 Hyperthyroid heart disease:","Include as part of the overall evaluation for hyperthyroidism under DC 7900.","However, when atrial fibrillation is present, hyperthyroidism may be evaluated either under DC 7900 or under DC 7010 (supraventricular arrhythmia), whichever results in a higher evaluation.","13, 2014]"]},{"source":"38 CFR","section":"Schedule of ratings - endocrine system.","date":"2017-12-10","url":"https://www.ecfr.gov/current/title-38/section-4.119","formatting_only":false,"added":["7900 Hyperthyroidism, including, but not limited to, Graves' disease:","For six months after initial diagnosis | 30","Thereafter, rate residuals of disease or complications of medical treatment within the appropriate diagnostic code(s) within the appropriate body system.","| Note (1):","If hyperthyroid cardiovascular or cardiac disease is present, separately evaluate under DC 7008 (hyperthyroid heart disease).","| Note (2):","Separately evaluate eye involvement occurring as a manifestation of Graves' Disease as diplopia (DC 6090);","impairment of central visual acuity (DCs 6061-6066);"],"removed":["Link to an amendment published at 82 FR 50804, Nov.","2, 2017.","7900 Hyperthyroidism |","Thyroid enlargement, tachycardia (more than 100 beats per minute), eye involvement, muscular weakness, loss of weight, and sympathetic nervous system, cardiovascular, or astrointestinal symptoms | 100","Emotional instability, tachycardia, fatigability, and increased pulse pressure or blood pressure | 60","Tachycardia, tremor, and increased pulse pressure or blood pressure | 30","Tachycardia, which may be intermittent, and tremor, or;","continuous medication required for control | 10"]},{"source":"38 CFR","section":"General rating considerations.","date":"2017-12-08","url":"https://www.ecfr.gov/current/title-38/section-3.321","formatting_only":false,"added":["Link to an amendment published at 82 FR 57835, Dec.","8, 2017."],"removed":[]}]}}